SPRB
Spruce Biosciences
$41.99
−$1.09 (−2.53%)Jul 27, 2026
Key metrics
The numbers that frame SPRB today
- Market cap
- $115.57M
- P/E (TTM)
- -3.1
- EV / FCF
- -2.3
- ROIC
- 1,096.5%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $7.00
- 52wk High
- $240.00
Growth
Revenue and earnings trend for SPRB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about SPRB
Is Spruce Biosciences a good buy?
Hold. Spruce Biosciences has excellent momentum, but poor quality makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Spruce Biosciences is selling at a very high price.
What is the market capitalization of SPRB?
Spruce Biosciences's market capitalization is $115.57M.
What is the P/E ratio for SPRB stock?
Spruce Biosciences's current P/E ratio is -3.1.
What is the 52-week high for SPRB stock?
The 52-week high for Spruce Biosciences is $240.00. The current close of $41.99 is 82.5% below that high.
What is the 52-week low for SPRB stock?
The 52-week low for Spruce Biosciences is $7.00. The current close of $41.99 is 499.9% above that low.
Does SPRB stock pay dividends?
Spruce Biosciences does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for SPRB?
Spruce Biosciences's Debt / Equity ratio is 0.2.